| Literature DB >> 6114885 |
H K Uhthoff, J A Brunet, A Aggerwal, R Varin.
Abstract
The efficacy of quazepam (Sch-16134) 15 mg capsules as a hypnotic has been compared with that of placebo in a 9-day study, using a parallel-group design. The physician's global evaluation numerically favoured quazepam 63% (nineteen of thirty) over placebo 50% (fifteen of thirty). Furthermore, it demonstrated greater improvement in Hypnotic Activity Index and Sleep Quality Index from baseline scores, and caused no adverse reactions.Entities:
Mesh：
Substances：
Year: 1981 PMID： 6114885 DOI： 10.1177/030006058100900410
Source DB: PubMed Journal: J Int Med Res ISSN： 0300-0605 Impact factor: 1.671